Aspira Women's Health Inc.
AWHL· OTC
AWHLAspira Women's Health Inc.
Released May 19, 2025, during market hours
10-Q filed May 19, 2025, 49 days after period end · 0001641172-25-011399
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $2.28M | $2.15M | $2.32M | $1.89M |
| Net Income | -$1.85M | -$4.63M | -$6.58M | -$9.27M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.09 |
| -$0.39 |
| -$0.79 |
| -$1.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
